About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Oxymorphone Patch Program Update

May 14, 2015

Click here to read more

Post navigation

Chairman Resignation

Apppointment of Consultant to Assist in Commercialising TPM for the Mass Market

Related Posts

Phosphagenics Signs Development Agreement for TPM Oxymorphone Patch in Japan

August 22, 2017

New Agreement with Medterra Pharma

December 20, 2021December 20, 2021

Avecho receives US$3M upfront payment from Sandoz AG

March 28, 2025March 28, 2025

Recent Posts

Watch now: how significant is chronic insomnia in Australia?
October 14, 2026
Recruitent recommences for phase III insomnia trial
August 31, 2026
Euroz Hartleys | Successful Phase 3 Interim Results
July 8, 2026

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.